Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitors
US-9216182-B2 · Dec 22, 2015 · US
Histone deacetylase inhibitors
US10308608B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10308608-B2 |
| Application number | US-201816047179-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 27, 2018 |
| Priority date | Jul 2, 2015 |
| Publication date | Jun 4, 2019 |
| Grant date | Jun 4, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided herein are compounds and methods for inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
First claim
Opening claim text (preview).
What is claimed is: 1. A compound selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 2. The compound or salt of claim 1 , having a structure: 3. The compound or salt of claim 1 , having a structure: 4. The compound or salt of claim 1 , having a structure: 5. The compound or salt of claim 1 , having a structure: 6. The compound or salt of claim 1 , having a structure: 7. The compound or salt of claim 1 , having a structure: 8. The compound or salt of claim 1 , having a structure: 9. The compound or salt of claim 1 , having a structure: 10. The compound or salt of claim 1 , having a structure: 11. The compound or salt of claim 1 , having a structure: 12. The compound or salt of claim 1 , having a structure: 13. The compound or salt of claim 1 , having a structure: 14. The compound or salt of claim 1 , having a structure:
Assignees
Inventors
Classifications
Oxygen atoms · CPC title
with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system · CPC title
Nitrogen atoms not forming part of a nitro radical · CPC title
Oxygen atoms · CPC title
attached in position 4 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10308608B2 cover?
- Provided herein are compounds and methods for inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
- Who is the assignee on this patent?
- Biomarin Pharm Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D211/46. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).